Spire Wealth Management Arrowhead Pharmaceuticals, Inc. Transaction History

Spire Wealth Management

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022
SELL
$39.62 - $69.97 $4,001 - $7,066
-101 Closed
0 $0
Q4 2021

Jan 14, 2022
BUY
$58.09 - $82.51 $5,867 - $8,333
101 New
101 $7,000
Q2 2021

Jul 26, 2021
SELL
$62.15 - $90.32 $6,277 - $9,122
-101 Closed
0 $0
Q1 2021

May 21, 2021
BUY
$61.35 - $90.47 $6,196 - $9,137
101 New
101 $6,000

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
91.2M
Call Options Held
130K
Put Options Held
401K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.27B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email